|
FY2025
12 months to Jan 3, 2026
|
FY2024
12 months to Dec 28, 2024
|
FY2023
12 months to Dec 30, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Jan 1, 2022
|
|
|---|---|---|---|---|---|
| Revenue (Notes 1 and 11) | |||||
| Costs and Operating Expenses: | |||||
| Cost of revenue | |||||
| Selling, general, and administrative expenses | |||||
| Research and development expenses | |||||
| Other costs, net (Note 8) | |||||
| Total Costs and Operating Expenses | |||||
| Operating Income | |||||
| Interest Income | |||||
| Interest Expense | |||||
| Other Expense, Net | |||||
| Income Before Provision for Income Taxes | |||||
| Provision for Income Taxes (Note 5) | |||||
| Net Income | |||||
| Net Income Attributable to Noncontrolling Interests | |||||
| Net income attributable to Kadant | |||||
| Earnings per Share Attributable to Kadant (Note 12) | |||||
| Basic (in dollars per share) | |||||
| Diluted (in dollars per share) | |||||
| Weighted Average Shares (Note 12) | |||||
| Basic (in shares) | |||||
| Diluted (in shares) | |||||
Loading...
